CD163 and breast cancer: Although the prognostic significance of TAMs in TCCRP remains undefined, the presence of a CD68+/CD163+ macrophage infiltrate, a signature associated with adverse features in broader breast cancer cohorts, was considered a potential high-risk factor in this individual case.